{"id":10741,"date":"2019-01-17T08:01:37","date_gmt":"2019-01-17T07:01:37","guid":{"rendered":"http:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/non-categorizzato\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/"},"modified":"2019-01-17T08:01:37","modified_gmt":"2019-01-17T07:01:37","slug":"che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/","title":{"rendered":"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma?"},"content":{"rendered":"<p>Nel mondo farmaceutico una delle normative pi\u00f9 importanti alle quali conformarsi \u00e8 il FDA CFR21 part 11. Che cos&#8217;\u00e8 \u00a0questa normativa, cos\u00ec importante, alla quale Yokogawa con i suoi sistemi di data logging &amp; recording risponde pienamente?<\/p>\n<p>Bene&#8230; immaginiamo un impianto di produzione farmaceutica che produce alcuni farmaci per le malattie cardiache. Potete ben immaginare che eventuali errori nella produzione, misurazioni errate o impostazioni errate dei dispositivi (e errori umani) potrebbero portare a tragici eventi influendo drammaticamente sulla salute delle persone.<br \/>\nIn base a quanto sopra \u00e8 obbligatorio quindi trovare alcune regole da seguire per essere in grado di tracciare e rilevare eventuali errori e\/o anomalie prima che queste possano portare a gravi conseguenze.<br \/>\nQuanto sopra \u00e8 lo scopo del FDA CFR21 part 11.<\/p>\n<p>Il nucleo di base delle regole della normativa di cui sopra \u00e8 il seguente:<\/p>\n<p><em>1) tracciare e registrare qualsiasi impostazione o modifica delle impostazioni del dispositivo<\/em><\/p>\n<p><em>2) chi lo ha fatto<\/em><\/p>\n<p><em>3) garantire la qualit\u00e0 e l&#8217;incorruttibilit\u00e0 dei dati registrati<\/em><\/p>\n<p><em>4) impostare i profili degli utenti in termini di controllo completo, controllo parziale e \u201cuser\u201d per garantire la giusta delega delle responsabilit\u00e0 al giusto livello.<\/em><\/p>\n<p>A proposito di quanto detto in precedenza, qualsiasi dispositivo, conforme al FDA CFR21 part11, deve produrre e memorizzare un log chiamato audit trail; sulla \u00a0audit trail \u00a0deve essere scritto chi ha fatto cosa, e quando, in modo di rispondere pienamente a quanto scritto ai punti 1) e 2).<br \/>\nLa codifica dei dati deve garantire l&#8217;incorruttibilit\u00e0 dei dati registrati; in poche parole deve essere impossibile modificare manualmente i dati. Questo viene fatto da speciali algoritmi che codificano i dati in modo che eventuali modifiche vengano immediatamente rilevate e segnalate (garantendo quindi la conformit\u00e0 al punto 3).<br \/>\nLa gestione dei dispositivi da parte di un \u201camministratore\u201d, al fine \u00a0di \u00a0memorizzare nei dispositivi stessi tutti gli utenti e tutto ci\u00f2 che viene loro \u00a0consentito fare proporzionalmente al loro livello di responsabilit\u00e0 risponde, ultimo ma non ultimo, a quanto citato al punto 4).<\/p>\n<p>Alla fine tutto il sistema, se pienamente conforme alla normativa, \u00a0sar\u00e0 &#8220;validato&#8221; e pronto all&#8217;uso.<\/p>\n<p>Tutta la gamma dei data logger Yokogawa risponde pienamente a quanto sopra offrendo all\u2019utenza soluzioni di misura, controllo e registrazione a basso costo e ad altissime prestazioni in termine di potenza, modularit\u00e0 e flessibilit\u00e0.<\/p>\n<hr \/>\n<blockquote class=\"wp-embedded-content\" data-secret=\"5DB6X7k2Q1\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/1-sistemi-di-assistenza-1-i-nostri-piccoli-aiutanti-quotidiani\/\">1. Sistemi di assistenza \u2013 1. I nostri piccoli aiutanti quotidiani<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u201c1. Sistemi di assistenza \u2013 1. I nostri piccoli aiutanti quotidiani\u201d \u2014 Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/1-sistemi-di-assistenza-1-i-nostri-piccoli-aiutanti-quotidiani\/embed\/#?secret=hBRqgaVdq8#?secret=5DB6X7k2Q1\" data-secret=\"5DB6X7k2Q1\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"LvexAXC8Ke\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/sorveglianza-regolare-del-vostro-sistema-di-sicurezza-la-state-svolgendo-ed-e-efficace\/\">Sorveglianza regolare del vostro sistema di sicurezza: la state svolgendo ed \u00e8 efficace?<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u201cSorveglianza regolare del vostro sistema di sicurezza: la state svolgendo ed \u00e8 efficace?\u201d \u2014 Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/sorveglianza-regolare-del-vostro-sistema-di-sicurezza-la-state-svolgendo-ed-e-efficace\/embed\/#?secret=vVFRqEXXeU#?secret=LvexAXC8Ke\" data-secret=\"LvexAXC8Ke\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"0awuGjGCUq\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/sicurezza-degli-impianti-protezione-su-misura-per-i-vostri-gioielli-della-corona\/\">Sicurezza degli impianti \u2013 protezione su misura per i vostri gioielli della corona<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u201cSicurezza degli impianti \u2013 protezione su misura per i vostri gioielli della corona\u201d \u2014 Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/sicurezza-degli-impianti-protezione-su-misura-per-i-vostri-gioielli-della-corona\/embed\/#?secret=utwMOFlOYH#?secret=0awuGjGCUq\" data-secret=\"0awuGjGCUq\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharma: Potete ben immaginare che eventuali errori nella produzione, misurazioni errate o impostazioni errate dei dispositivi (e errori umani) potrebbero portare a tragici eventi influendo drammaticamente sulla salute delle persone.  In base a quanto sopra \u00e8 obbligatorio quindi trovare alcune regole da seguire per essere in grado di tracciare e rilevare eventuali errori e\/o anomalie prima che queste possano portare a gravi conseguenze.<br \/>\nQuanto sopra \u00e8 lo scopo del FDA CFR21 part 11.<\/p>\n","protected":false},"author":128,"featured_media":10743,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[2042,55],"tags":[2132,2134,2152,2135,260,2139,2136],"coauthors":[2151],"class_list":["post-10741","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-automazione","category-life-science","tag-automazione","tag-digitalizzazione","tag-fda-cfr21-part-11","tag-industria-4-0","tag-pharma","tag-servizi","tag-tecnica","author-cap-luca-rizzardi"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma? - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma?\" \/>\n<meta property=\"og:description\" content=\"Pharma: Potete ben immaginare che eventuali errori nella produzione, misurazioni errate o impostazioni errate dei dispositivi (e errori umani) potrebbero portare a tragici eventi influendo drammaticamente sulla salute delle persone. In base a quanto sopra \u00e8 obbligatorio quindi trovare alcune regole da seguire per essere in grado di tracciare e rilevare eventuali errori e\/o anomalie prima che queste possano portare a gravi conseguenze. Quanto sopra \u00e8 lo scopo del FDA CFR21 part 11.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-17T07:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"849\" \/>\n\t<meta property=\"og:image:height\" content=\"566\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luca Rizzardi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/\"},\"author\":{\"name\":\"Luca Rizzardi\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#\\\/schema\\\/person\\\/c682658931d42b7947e77f5039a3d967\"},\"headline\":\"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma?\",\"datePublished\":\"2019-01-17T07:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/\"},\"wordCount\":407,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Fotolia_157125815_S.jpg\",\"keywords\":[\"Automazione\",\"digitalizzazione\",\"FDA CFR21 part 11\",\"industria 4.0\",\"Pharma\",\"Servizi\",\"Tecnica\"],\"articleSection\":[\"Automazione\",\"Life Science\"],\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/\",\"name\":\"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma? - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Fotolia_157125815_S.jpg\",\"datePublished\":\"2019-01-17T07:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Fotolia_157125815_S.jpg\",\"contentUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Fotolia_157125815_S.jpg\",\"width\":849,\"height\":566,\"caption\":\"Production line of beauty and healthcare products at plant or factory. Process of manufacturing and packaging cosmetics goods. Glass or plastic bottles with screw caps standing on conveyor belt\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Just another blogs.yokogawa.com Sites site\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/05\\\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/05\\\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/#\\\/schema\\\/person\\\/c682658931d42b7947e77f5039a3d967\",\"name\":\"Luca Rizzardi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14805c2c82c58cca178afd86543257f7a04c30721a76ad72f5181263a4278a4b?s=96&d=mm&r=ga24871d2c44a7cf6263771dba9455de7\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14805c2c82c58cca178afd86543257f7a04c30721a76ad72f5181263a4278a4b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14805c2c82c58cca178afd86543257f7a04c30721a76ad72f5181263a4278a4b?s=96&d=mm&r=g\",\"caption\":\"Luca Rizzardi\"},\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/it\\\/author\\\/luca-rizzardi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma? - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/","og_locale":"it_IT","og_type":"article","og_title":"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma?","og_description":"Pharma: Potete ben immaginare che eventuali errori nella produzione, misurazioni errate o impostazioni errate dei dispositivi (e errori umani) potrebbero portare a tragici eventi influendo drammaticamente sulla salute delle persone. In base a quanto sopra \u00e8 obbligatorio quindi trovare alcune regole da seguire per essere in grado di tracciare e rilevare eventuali errori e\/o anomalie prima che queste possano portare a gravi conseguenze. Quanto sopra \u00e8 lo scopo del FDA CFR21 part 11.","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2019-01-17T07:01:37+00:00","og_image":[{"width":849,"height":566,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg","type":"image\/jpeg"}],"author":"Luca Rizzardi","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/"},"author":{"name":"Luca Rizzardi","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#\/schema\/person\/c682658931d42b7947e77f5039a3d967"},"headline":"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma?","datePublished":"2019-01-17T07:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/"},"wordCount":407,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#organization"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg","keywords":["Automazione","digitalizzazione","FDA CFR21 part 11","industria 4.0","Pharma","Servizi","Tecnica"],"articleSection":["Automazione","Life Science"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/","name":"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma? - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/#primaryimage"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg","datePublished":"2019-01-17T07:01:37+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/#primaryimage","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg","width":849,"height":566,"caption":"Production line of beauty and healthcare products at plant or factory. Process of manufacturing and packaging cosmetics goods. Glass or plastic bottles with screw caps standing on conveyor belt"},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/che-cose-il-fda-cfr21-part-11-per-il-mondo-del-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/"},{"@type":"ListItem","position":2,"name":"Che cos\u2019\u00e8 il FDA CFR21 part 11 per il mondo del pharma?"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/","name":"Chemical Pharma Blog","description":"Just another blogs.yokogawa.com Sites site","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/#\/schema\/person\/c682658931d42b7947e77f5039a3d967","name":"Luca Rizzardi","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/14805c2c82c58cca178afd86543257f7a04c30721a76ad72f5181263a4278a4b?s=96&d=mm&r=ga24871d2c44a7cf6263771dba9455de7","url":"https:\/\/secure.gravatar.com\/avatar\/14805c2c82c58cca178afd86543257f7a04c30721a76ad72f5181263a4278a4b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/14805c2c82c58cca178afd86543257f7a04c30721a76ad72f5181263a4278a4b?s=96&d=mm&r=g","caption":"Luca Rizzardi"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/author\/luca-rizzardi\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg",849,566,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S-768x512.jpg",768,512,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg",849,566,false],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg",849,566,false],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S.jpg",849,566,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_157125815_S-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Luca Rizzardi","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/author\/luca-rizzardi\/"},"uagb_comment_info":0,"uagb_excerpt":"Pharma: Potete ben immaginare che eventuali errori nella produzione, misurazioni errate o impostazioni errate dei dispositivi (e errori umani) potrebbero portare a tragici eventi influendo drammaticamente sulla salute delle persone. In base a quanto sopra \u00e8 obbligatorio quindi trovare alcune regole da seguire per essere in grado di tracciare e rilevare eventuali errori e\/o anomalie&hellip;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/posts\/10741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/users\/128"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/comments?post=10741"}],"version-history":[{"count":0,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/posts\/10741\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/media\/10743"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/media?parent=10741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/categories?post=10741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/tags?post=10741"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/it\/wp-json\/wp\/v2\/coauthors?post=10741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}